Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Consolidated Net Income: 2019-2024

Historic Consolidated Net Income for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to -$327.0 million.

  • IDEAYA Biosciences' Consolidated Net Income rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
  • According to the latest figures from FY2024, IDEAYA Biosciences' Consolidated Net Income is -$327.0 million, which was down 143.23% from -$134.4 million recorded in FY2023.
  • IDEAYA Biosciences' Consolidated Net Income's 5-year high stood at -$35.3 million during FY2020, with a 5-year trough of -$327.0 million in FY2024.
  • Over the past 3 years, IDEAYA Biosciences' median Consolidated Net Income value was -$134.4 million (recorded in 2023), while the average stood at -$174.6 million.
  • In the last 5 years, IDEAYA Biosciences' Consolidated Net Income climbed by 20.16% in 2020 and then crashed by 143.23% in 2024.
  • Over the past 5 years, IDEAYA Biosciences' Consolidated Net Income (Yearly) stood at -$35.3 million in 2020, then crashed by 42.22% to -$50.3 million in 2021, then decreased by 24.34% to -$62.5 million in 2022, then slumped by 115.08% to -$134.4 million in 2023, then slumped by 143.23% to -$327.0 million in 2024.